14 May 2021 --- This week in nutrition news, Chr. Hansen and Nestlé laid their year-long HMO patent dispute to rest, with both parties withdrawing their respective litigations and oppositions. Also, Progress Biotech received EU approval for the use of its algal oil in infant formula. In research strides, Giellepi received clinical evidence that its diosmin alleviates leg pain.
